X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs FDC LTD. - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD FDC LTD. WYETH LTD/
FDC LTD.
 
P/E (TTM) x 27.7 22.2 124.8% View Chart
P/BV x 5.3 5.0 107.1% View Chart
Dividend Yield % 1.3 0.9 134.4%  

Financials

 WYETH LTD   FDC LTD.
EQUITY SHARE DATA
    WYETH LTD
Mar-13
FDC LTD.
Mar-14
WYETH LTD/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs1,044144 727.8%   
Low Rs81879 1,035.4%   
Sales per share (Unadj.) Rs298.647.6 627.7%  
Earnings per share (Unadj.) Rs57.27.6 752.2%  
Cash flow per share (Unadj.) Rs58.49.0 648.3%  
Dividends per share (Unadj.) Rs17.002.25 755.6%  
Dividend yield (eoy) %1.82.0 90.3%  
Book value per share (Unadj.) Rs249.547.5 524.8%  
Shares outstanding (eoy) m22.72177.83 12.8%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x3.12.3 133.3%   
Avg P/E ratio x16.314.6 111.3%  
P/CF ratio (eoy) x15.912.3 129.1%  
Price / Book Value ratio x3.72.3 159.5%  
Dividend payout %29.729.6 100.4%   
Avg Mkt Cap Rs m21,15719,784 106.9%   
No. of employees `0000.5NA-   
Total wages/salary Rs m4001,221 32.8%   
Avg. sales/employee Rs Th13,787.4NM-  
Avg. wages/employee Rs Th813.0NM-  
Avg. net profit/employee Rs Th2,643.3NM-  
INCOME DATA
Net Sales Rs m6,7838,459 80.2%  
Other income Rs m353394 89.6%   
Total revenues Rs m7,1368,852 80.6%   
Gross profit Rs m1,6172,070 78.1%  
Depreciation Rs m27249 10.7%   
Interest Rs m631 17.7%   
Profit before tax Rs m1,9382,184 88.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-225 0.0%   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m632606 104.4%   
Profit after tax Rs m1,3011,353 96.1%  
Gross profit margin %23.824.5 97.4%  
Effective tax rate %32.627.7 117.6%   
Net profit margin %19.216.0 119.8%  
BALANCE SHEET DATA
Current assets Rs m6,9844,355 160.4%   
Current liabilities Rs m2,0561,792 114.7%   
Net working cap to sales %72.630.3 239.7%  
Current ratio x3.42.4 139.8%  
Inventory Days Days9944 223.3%  
Debtors Days Days2425 97.1%  
Net fixed assets Rs m2443,025 8.1%   
Share capital Rs m227179 127.2%   
"Free" reserves Rs m5,4418,243 66.0%   
Net worth Rs m5,6688,453 67.1%   
Long term debt Rs m2511 233.6%   
Total assets Rs m7,90110,557 74.8%  
Interest coverage x353.371.4 494.7%   
Debt to equity ratio x00 348.4%  
Sales to assets ratio x0.90.8 107.2%   
Return on assets %16.513.1 126.1%  
Return on equity %22.916.0 143.3%  
Return on capital %34.023.5 144.8%  
Exports to sales %0.213.3 1.6%   
Imports to sales %36.33.3 1,087.1%   
Exports (fob) Rs m151,126 1.3%   
Imports (cif) Rs m2,465283 871.8%   
Fx inflow Rs m151,146 1.3%   
Fx outflow Rs m2,677355 753.5%   
Net fx Rs m-2,662791 -336.6%   
CASH FLOW
From Operations Rs m9231,485 62.2%  
From Investments Rs m317-620 -51.2%  
From Financial Activity Rs m-481-753 63.9%  
Net Cashflow Rs m759113 673.0%  

Share Holding

Indian Promoters % 0.0 68.9 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 4.7 240.4%  
FIIs % 7.2 7.5 96.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 19.0 160.0%  
Shareholders   21,978 23,730 92.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   SHASUN PHARMA  DR. REDDYS LAB  ABBOTT INDIA  UNICHEM LAB  MERCK LTD  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY18); Net Profit Down 35.8% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, FDC LTD. has posted a net profit of Rs 315 m (down 35.8% YoY). Sales on the other hand came in at Rs 3 bn (up 5.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - DIVIS LABORATORIES COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS